Select your location
group-women-sports-teams

News & Media

Take a look inside our world

Press Releases

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
View all press releases

Feature stories

Coming Home to Teva: Rediscovering Purpose and Community
little boys hugging smiling

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine
Woman using inhaler device for asthma

Medical Device Engineering: the Teva Story
Dr Beatrice Wiafe Addai addressing breast cancer meeting in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana
Mark DeStefano, Director of Global Technology Innovation for the CPD R&D group at Teva

3 Trends I’m Watching in Drug Delivery Devices
Beryl Ojwang, MD, MBA, MPH, Global Associate Medical Director in Neuroscience, shares how technology helps generate patient insights for Teva scientists.

“AI helps us better understand and support patient needs”
Teva team outdoor

Teva Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index
Teva scientist working on duvakitug in lab

Addressing the unmet needs of Inflammatory Bowel Disease patients
Konstantina Katcheves, SVP Innovative Business Development

3 Trends

3 Trends I’m Watching in Pharma Business Development
Two women standing in a forest

Goodbye? More Like “See You Later!” Teva’s Boomerang Employees
View all stories

Contacts for Media Inquiries

Kelley Dougherty

North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com

Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com